Dimethylformamide → HCID 18426849, compound
Reaction equation
Br[C:2]1[S:3][C:4]([C:7]2[NH:8][C:9]3[CH:15]=[C:14]([Cl:16])[C:13]([Cl:17])=[CH:12][C:10]=3[N:11]=2)=[CH:5][CH:6]=1.[Na].C([Li])CCC.CN(C)[CH:26]=[O:27]>O1CCCC1.O>[CH:26]([C:2]1[S:3][C:4]([C:7]2[NH:8][C:9]3[CH:15]=[C:14]([Cl:16])[C:13]([Cl:17])=[CH:12][C:10]=3[N:11]=2)=[CH:5][CH:6]=1)=[O:27]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- -78 °C
Procedure
To a solution of 2-(2-bromothiophen-5-yl)-5,6-dichlorobenzimidazole (100 mg, 0.287 mmol) in tetrahydrofuran (6 mL) was added sodium hydryde (60% oil dispersion; 14 mg, 0.35 mmol) at 0° C. under nitrogen atmosphere. After cooling to −78° C., n-butyllithium (1.6 mol/L in hexane; 0.36 mL, 0.57 mmol), dimethylformamide (0.085 mL, 1.1 mmol) were added, and the mixture was stirred for 10 min. Water was added, and the mixture was extracted with ethyl acetate. The organic layer was washed with water and brine and dried on anhydrous sodium sulfate. The solvent was evaporated under reduced pressure, and the residue was purified by silica gel column chromatography (19:1 to 9:1 chloroform/acetonitrle) to afford 2-(2-formylthiophen-5-yl)-5,6-dichlorobenzimidazole (36 mg, 42%).
Workup
- extractionthe mixture was extracted with ethyl acetate
- washThe organic layer was washed with water and brine
- dry with materialdried on anhydrous sodium sulfate
- customThe solvent was evaporated under reduced pressure
- customthe residue was purified by silica gel column chromatography (19:1 to 9:1 chloroform/acetonitrle)
Sources & evidence
- ORD record
- ord-34e9119adb3a4e99b267fa235584b935
- Source dataset
- uspto-grants-2002_09
- Patent number
- US06452014B1
Reaction notes
Loading…